Literature DB >> 18085661

Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes.

I-Fang Lee1, Huilian Qin, John J Priatel, Rusung Tan.   

Abstract

Autoimmune diabetes in nonobese diabetic (NOD) mice can be prevented by a single injection of complete Freund's adjuvant (CFA), but the mechanisms mediating protection remains unclear. We previously showed that NOD mice immunized with CFA have a markedly reduced incidence of diabetes that is associated with a significant decrease in the number of beta-cell-specific, autoreactive cytotoxic T lymphocytes and, furthermore, that the effect of CFA is mediated by natural killer (NK) cells. In this study, we report one mechanism by which NK cells regulate the onset of diabetes. Administration of CFA produced a rapid increase in NK cell frequency and function, including cytotoxicity and IFN-gamma secretion. By co-transferring NK cells from IFN-gamma-deficient (or wild-type) NOD mice and spleen cells from diabetic NOD mice to NOD/SCID recipients, we show that IFN-gamma secretion by NK cells significantly influences the effect of CFA protection. In contrast, NK cytotoxicity does not appear to participate in CFA-mediated protection from diabetes. Our findings demonstrate that NK cells mediate the protective effects of CFA through secretion of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18085661     DOI: 10.1002/eji.200737189

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  Innate immunity and the pathogenesis of type 1 diabetes.

Authors:  Fabio Arturo Grieco; Francesco Vendrame; Isabella Spagnuolo; Francesco Dotta
Journal:  Semin Immunopathol       Date:  2010-04-10       Impact factor: 9.623

2.  Macrophages from nonobese diabetic mouse have a selective defect in IFN-γ but not IFN-α/β receptor pathway.

Authors:  Myung-Shik Lee; Hyung-Joon Kwon; Hun Sik Kim
Journal:  J Clin Immunol       Date:  2012-03-07       Impact factor: 8.317

3.  Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirus.

Authors:  Mark T Orr; Joshua N Beilke; Irina Proekt; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

4.  Treatment with incomplete Freund's adjuvant and Listeria monocytogenes delays diabetes via an interleukin-17-secretion-independent pathway.

Authors:  Hai-Ping Wang; Zhi-Gao He
Journal:  Exp Ther Med       Date:  2015-03-03       Impact factor: 2.447

5.  Collagen-induced arthritis: severity and immune response attenuation using multivalent N-acetyl glucosamine.

Authors:  J Richter; K Capková; V Hříbalová; L Vannucci; I Danyi; M Malý; A Fišerová
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

Review 6.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

7.  Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling.

Authors:  Huilian Qin; I-Fang Lee; Constadina Panagiotopoulos; Xiaoxia Wang; Alvina D Chu; Paul J Utz; John J Priatel; Rusung Tan
Journal:  Diabetes       Date:  2011-01-26       Impact factor: 9.461

8.  NK cells are not required for spontaneous autoimmune diabetes in NOD mice.

Authors:  Joshua N Beilke; Craig T Meagher; Karoline Hosiawa; Marine Champsaur; Jeffrey A Bluestone; Lewis L Lanier
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

9.  Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes.

Authors:  Jung Hye Kim; Kahui Park; Sang Bae Lee; Shinae Kang; Jong Suk Park; Chul Woo Ahn; Ji Sun Nam
Journal:  J Diabetes Investig       Date:  2019-02-05       Impact factor: 4.232

10.  NK Cells Regulate CD8+ T Cell Mediated Autoimmunity.

Authors:  Philipp A Lang; Sarah Q Crome; Haifeng C Xu; Karl S Lang; Laurence Chapatte; Elissa K Deenick; Melanie Grusdat; Aleksandra A Pandyra; Vitaly I Pozdeev; Ruifeng Wang; Tobias A W Holderried; Harvey Cantor; Andreas Diefenbach; Alisha R Elford; David R McIlwain; Mike Recher; Dieter Häussinger; Tak W Mak; Pamela S Ohashi
Journal:  Front Cell Infect Microbiol       Date:  2020-02-13       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.